NRX Pharmaceuticals (NRXP) P/E Ratio
P/E Ratio as of Jun 13, 2025: -1.71
Average-1.45
Median-1.35
Minimum-1.83
Maximum-1.22
-1.71
Past Month-0.51 (42.50%)
The P/E ratio for NRX Pharmaceuticals (NRXP) is -1.71 as of Jun 13, 2025. This represents a increase of 92.13% compared to its 12-month average P/E ratio of -0.89. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
NRX Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
NRX Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NRX Pharmaceuticals to industry peers.
NRX Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
NRX Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NRX Pharmaceuticals to industry peers.
NRX Pharmaceuticals (NRXP) P/E Ratio Insights
See NRX Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NRX Pharmaceuticals (NRXP)
Order type
Buy in
Order amount
Est. shares
0 shares
NRX Pharmaceuticals (NRXP) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $2.68 | -1.33 |
| May 1, 2025 | $2.08 | -0.86 |
| Apr 1, 2025 | $1.94 | -0.81 |
| Mar 3, 2025 | $2.03 | -0.94 |
| Feb 3, 2025 | $2.80 | -1.30 |
| Jan 2, 2025 | $2.99 | -1.39 |
NRX Pharmaceuticals (NRXP) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.71 | +67.65% |
| 2024 | -1.02 | +13.33% |
| 2023 | -0.90 | -21.05% |
| 2022 | -1.14 | +90.00% |
| 2021 | -0.60 | -99.59% |
| 2020 | -146.59 | — |
FAQs About NRX Pharmaceuticals (NRXP) P/E ratio
The latest P/E ratio of NRX Pharmaceuticals (NRXP) is -1.71, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
NRX Pharmaceuticals’s last 12-month average P/E ratio is -0.89, compared to its current P/E ratio of -1.71. This reflects a increase of 92.13%.
NRX Pharmaceuticals’s current P/E ratio of -1.71 is higher than its last 12-month average P/E of -0.89. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
NRX Pharmaceuticals’s average P/E ratio over the last 3 years is -0.97. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
NRX Pharmaceuticals’s average P/E ratio over the last 5 years is -68.18. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.